CD14 protein as a modulator of the inflammatory response

Anna Ciesielska1, Ichrak Ben Amor1, Katarzyna Kwiatkowska1

  • 1Pracownia Biologii Molekularnej Błony Komórkowej, Instytut Biologii Doświadczalnej im. M. Nenckiego PAN, Warszawa.

Postepy Biochemii
|July 16, 2024
PubMed

Insights

Cluster of Differentiation 14 (CD14) protein is crucial for immune cell inflammatory responses by binding lipopolysaccharide (LPS) and activating Toll-like receptor 4 (TLR4) signaling. Its role extends to non-infectious diseases like autoimmune and cardiovascular conditions.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Cluster of Differentiation 14 (CD14) is a key protein in the immune system's inflammatory response.
  • CD14 facilitates the recognition of bacterial lipopolysaccharide (LPS) by immune cells.
  • It plays a critical role in initiating signaling cascades essential for combating infections.

Purpose of the Study:

  • To elucidate the multifaceted roles of CD14 in immune response activation.
  • To highlight CD14's function as both a transporter and regulator of Toll-like receptor 4 (TLR4) activity.
  • To explore the emerging significance of CD14 in non-infectious disease pathogenesis.

Main Methods:

  • The study focuses on the molecular interactions of CD14 with LPS and the TLR4-MD-2 complex.
  • Mechanisms of CD14-mediated endotoxin transport and receptor regulation were investigated.
  • Literature review and analysis of current research on CD14's involvement in various disease states.

Main Results:

  • CD14 binds LPS and transfers it to the TLR4-MD-2 complex, initiating pro-inflammatory signaling.
  • CD14 acts as a crucial transporter and regulator for LPS and other microbial/endogenous molecules.
  • CD14's involvement is increasingly recognized in non-infectious diseases, including autoimmune, metabolic, and cardiovascular conditions.

Conclusions:

  • CD14 is a central mediator of inflammatory responses to pathogens.
  • Its regulatory functions extend beyond infection, impacting chronic non-infectious diseases.
  • Further research into CD14's role is vital for understanding and treating a spectrum of inflammatory and non-infectious disorders.

Related Concept Videos

Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
990
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
127
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K